Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3145 results found
Expand All
Apply All
3145 results found

What to know about the spending bill
Share
Good Day BIO Newsletter  •  October 2, 2023
A very quick update on what’s been happening on Capitol Hill and why it matters to biotech—plus, meet BIO’s new agriculture and environment working groups. (556 words, 2 minutes, 46 seconds)
Read More

BIO Comments to the Department of Defense (DoD), General Services Administration (GSA), and National Aeronautics and Space Administration (NASA)
Share
Letters, Testimony & Comments  •  September 29, 2023
BIO submitted comments to DoD, GSA, and NASA on the Proposed Rule to amend and restructure regulations on environmental and sustainability procurement (FAR Case 2022-006, Docket No. 2022-0006, Sequence No. 1 RIN 9000-AO43)
Read More

PBM transparency bill introduced
Share
Good Day BIO Newsletter  •  September 29, 2023
While we wait to see what happens with government funding before tomorrow’s deadline, we have news on a new PBM transparency bill, a new collaboration to help patients enroll in clinical trials, and a win for patients with Pompe disease. (590 words, 2 minutes, 57 seconds)
Read More

BIO Membership Mingle
Share
September 28, 2023
Network with BIO members and meet with BIO’s policy staff, membership team, and cost-savings partners. Refreshments and light appetizers will be served. RSVP by September 21.  
Read More

BIO's Comments on FTC Merger Guidelines
Share
Letters, Testimony & Comments  •  September 28, 2023

Voters support the Bayh-Dole Act
Share
Good Day BIO Newsletter  •  September 28, 2023
A new poll shows voters like the Bayh-Dole Act—but not when it’s used for price controls. Plus, catch up on what’s been happening with PBMs and what we’re watching during World Alzheimer’s Month. (545 words, 2 minutes, 43 seconds)
Read More

New BIO Working Groups Give Growing Ag & Environment Biotech Sector a Public Policy Voice
Share
Press Release  •  September 27, 2023
Updated regulatory working groups announced today by the Biotechnology Innovation Organization (BIO) reflect the rapidly increasing diversity and impact of BIO’s Agriculture & Environment membership and ensure that all member companies’ regulatory and policy needs are met. BIO’s Agriculture & Environment regulatory working groups now include an Agricultural Biologicals Working Group and a Biobased Manufacturing Working Group, as well as a Plant Working Group and an Animal Working Group. The major change in the working group structure is the creation of the Agricultural Biologicals Working Group and the Biobased Manufacturing Working Group, which reflects the growth of both sectors. The agricultural biologicals sector includes, but is not limited to, food ingredients, enzymes for food processing, alternative proteins, and small molecules and microbes for crop inputs. The biobased manufacturing sector includes biobased energy, biochemicals, bioplastics, biobased materials and other products of industrial biotechnology. The reorganized working groups have more-clearly established priorities and objectives, giving members greater opportunity to drive policy and work for a balanced regulatory structure that benefits agriculture, industry and consumers. “By having a clear home for the different pipelines of members and prospective members, as well as the biotech scientific community, we are able to tackle the most pressing issues and show value to the industry,” said Beth Ellikidis, BIO’s vice president for Agriculture & Environment. “No other group has the diversity of membership and knowledge of biotech’s positive impacts for agriculture, climate and growing the bioeconomy.” Dr. Leah Buchman, BIO’s senior manager for Agriculture & Environment Regulatory Policy, said policy makers and regulatory agencies will benefit, as well. “Agencies and policy makers look to BIO as the leader in agricultural and industrial biotechnology,” said Buchman. “Our…
Read More

BIO Comments to FTC on Revised HSR Form
Share
Letters, Testimony & Comments  •  September 27, 2023
Comments on Revised HSR Premerger Notification and Report Form 16 CFR Parts 801-803—Hart-Scott-Rodino Coverage, Exemption, and Transmittal Rules, Project No. P239300
Read More
FTC HSR Comments

ICER still ignores patient concerns
Share
Good Day BIO Newsletter  •  September 27, 2023
We take a deep dive into ICER’s updated treatment assessment—plus, how biotech is making crops more resilient in the face of an increasingly harsher climate. (609 words, 3 minutes, 2 seconds)
Read More

Inflation Reduction Act One Year Later— Where Are We Now? What Other Challenges are on the Horizon?
Share
Webinars  •  September 27, 2023
​It's been one year since the passage of the IRA. The Centers for Medicare & Medicaid Services has moved forward implementing the law's various provisions, including the new Medicare negotiation program and the redesign of the Medicare Part D benefit. Learn the latest developments from our panel of experts, including how the IRA is impacting biopharmaceutical companies today. Panelists delve into other important issues beyond the IRA, including new developments in Medicaid, 340B, and the emergence of Prescription Drug Affordability Boards in a number of states.  
Read More
photo of pills in capped bottles

Pagination

  • First First page
  • Prev Previous page
  • …
  • 82
  • 83
  • 84
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO